Ethical Goals and Design Criteria for ‘Fair Access” to Drugs in the US Health Care System

from News at https://bit.ly/39tR7sZ on March 31, 2021 at 09:43AM

In the contentious debate around US drug prices, less well understood is: if the price of a drug is a fair, value-based, price, how we assess if insurance coverage provides patients with ‘fair access’ to that drug? This paper from ICER and OHE authors seeks to define fair access. It proposes Ethical Goals for Access and Fair Design Criteria for cost-sharing and prior authorisation protocols.